Old Web
English
Sign In
Acemap
>
Paper
>
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.
2019
Maciag
Leverson
Alzate
Facon
Enschede
Punnoose
Verdugo
Ross
Amiot
Vij
Mikhael
Touzeau
Moreau
Dunbar
Benboubker
Xu
Pegourie
Agarwal
Gasparetto
Kaufman
Kumar
Keywords:
Targeted therapy
Oncology
relapsed refractory
Venetoclax
Multiple myeloma
Medicine
Internal medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]